Cargando…
Multiplex Protein Biomarker Profiling in Patients with Familial Hypercholesterolemia
Familial hypercholesterolemia (FH), is an autosomal dominant disorder caused by mutations in the LDLR, APOB, PCSK9, and APOE genes and is characterized by high plasma levels of total and low-density lipoprotein (LDL) cholesterol. Our study aimed to analyze the influences of two different therapies o...
Autores principales: | Dlouha, Dana, Blaha, Milan, Rohlova, Eva, Hubacek, Jaroslav A., Lanska, Vera, Visek, Jakub, Blaha, Vladimir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8535274/ https://www.ncbi.nlm.nih.gov/pubmed/34680994 http://dx.doi.org/10.3390/genes12101599 |
Ejemplares similares
-
Long-Term LDL-Apheresis Treatment and Dynamics of Circulating miRNAs in Patients with Severe Familial Hypercholesterolemia
por: Dlouha, Dana, et al.
Publicado: (2023) -
Monitoring of up to 15 years effects of lipoprotein apheresis on lipids, biomarkers of inflammation, and soluble endoglin in familial hypercholesterolemia patients
por: Víšek, J., et al.
Publicado: (2021) -
Genetics of Familial Hypercholesterolemia: New Insights
por: Vrablik, Michal, et al.
Publicado: (2020) -
Posttransplant Complications and Genetic Loci Involved in Telomere Maintenance in Heart Transplant Patients
por: Dlouha, Dana, et al.
Publicado: (2022) -
Preservation of the Photoreceptor Inner/Outer Segment Junction in Dry Age-Related Macular Degeneration Treated by Rheohemapheresis
por: Rencová, Eva, et al.
Publicado: (2015)